301
Views
25
CrossRef citations to date
0
Altmetric
Review

Immune deficiency in chronic rhinosinusitis: screening and treatment

&
Pages 117-123 | Received 09 May 2016, Accepted 21 Jul 2016, Published online: 18 Aug 2016

References

  • Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113:347–385.
  • Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011;128:693–707.
  • Schwitzguébel AJ, Jandus P, Lacroix JS, et al. Immunoglobulin deficiency in patients with chronic rhinosinusitis: systematic review of the literature and meta-analysis. J Allergy Clin Immunol. 2015;136:1523–1531.
  • Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–1205.
  • Alqudah M, Graham SM, Ballas ZK. High prevalence of humoral immunodeficiency patients with refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24:409–412.
  • Odat H, Alqudah M. Prevalence and pattern of humoral immunodeficiency in chronic refractory sinusitis. Eur Arch Otorhinolaryngol. 2016. doi:10.1007/s00405-016-3981-x. [Epub ahead of print].
  • Ryan MW, Brooks EG. Rhinosinusitis and comorbidities. Curr Allergy Asthma Rep. 2010;10:188–193.
  • Mahdavinia M, Grammer LC III. Chronic rhinosinusitis and age: is the pathogenesis different? Expert Rev Anti Infect Ther. 2013;11:1029–1040.
  • Nayan S, Alizadehfar R, Desrosiers M. Humoral primary immunodeficiencies in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15:46.
  • Bright PD, Rooney N, Virgo PF, et al. Laboratory clues to immunodeficiency; missed chances for early diagnosis? J Clin Pathol. 2015;68:1–5.
  • Holding S, Jolles S. Current screening approaches for antibody deficiency. Curr Opin Allergy Clin Immunol. 2015;15:547–555.
  • Holding S, Khan S, Sewell WA, et al. Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project. Ann Clin Biochem. 2015;52:319–326.
  • Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:38–59.
  • Agondi RC, Barros MT, Kokron CM, et al. Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy. 2013;27:79–83.
  • Ozcan C, Metin A, Erkocoglu M, et al. Allergic diseases in children with primary immunodeficiencies. Turk J Pediatr. 2014;56:41–47.
  • Ameratunga R, Storey P, Barker R, et al. Application of diagnostic and treatment criteria for common variable immunodeficiency disorder. Expert Rev Clin Immunol. 2016;12:257–266.
  • Ameratunga R, Brewerton M, Slade C, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5:415.
  • Seppänen M, Aghamohammadi A, Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? Clin Exp Immunol. 2014;10:1–5.
  • Gathmann B, Mahlaoui N, Gerard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–126.
  • Driessen GJ, Van Zelm MC, Van Hagen PM, et al. B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood. 2011;118:6814–6823.
  • Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–1657.
  • Angulo-Pérez G, Vivar-Acevedo E, Vargas-Aguayo A, et al. Prevalence, location and tomographic severity of chronic rhinosinusitis in adult patients with common variable immunodeficiency. Rev Alerg Mex. 2015;62:15–21.
  • Orange JS, Ballow M, Stiehm ER, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012;130:S1–S24.
  • Carr TF, Koterba AP, Chandra R, et al. Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25:241–244.
  • Kashani S, Carr TF, Grammer LC, et al. Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency. J Allergy Clin Immunol. 2015;3:236–242.
  • Ocampo CJ, Peters AT. Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness. Am J Rhinol Allergy. 2013;27:34–38.
  • Hupin C, Rombaux P, Bowen H, et al. Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic airway diseases. Allergy. 2013;68:1589–1597.
  • Alromaih S, Mfuna-Endam L, Bosse Y, et al. CD8A gene polymorphisms predict severity factors in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013;3:605–611.
  • Gabra N, Alromaih S, Endam LM, et al. Clinical features of cytotoxic CD8+ T-lymphocyte deficiency in chronic rhinosinusitis patients: a demographic and functional study. Int Forum Allergy Rhinol. 2014;4:495–501.
  • Duraisingham SS, Buckland M, Dempster J, et al. Primary vs secondary antibody deficiency: clinical feature and infection outcomes of immunoglobulin replacement. PLoS One. 2014;9:e100324.
  • Roberts DM, Jones RB, Smith RM, et al. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. J Autoimmun. 2015;57:60–65.
  • Barmettler S, Price C. Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab—for how long? J Allergy Clin Immunol. 2015;136:1407–1409.
  • Fernandez Romero DS, Torre MG, Larrauri BJ, et al. Rituximab and hypogammaglobulinemia. Medicina (B Aires). 2015;75:319–323.
  • Kaplan B, Kopyltsova Y, Khokhar A, et al. Rituximab and immune deficiency: case series and review of the literatura. J Allergy Clin Immunol Pract. 2014;2:594–600.
  • Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lyphoma Myeloma Leuk. 2013;13:106–111.
  • Gujadhur A, Thomson N, Aung AK, et al. CMV sinusitis in a HIV-negative renal transplant recipient. Transplantation. 2014;97:e55–7.
  • Sridhar S, Li IW, Wong SC, et al. Circulating cytomegalic cells in a patient with advanced HIV presenting with cytomegalovirus rhinosinusitis. J Clin Virol. 2015;65:87–89.
  • Myles IA, Gada S. Allergen immunotherapy in an HIV+ patient with allergic fungal rhinosinusitis. Case Reports Immunol. 2015;2015:875260.
  • Iacovou E, Vlastarakos PV, Papacharalampous G, et al. Diagnosis and treatment of HIV-associated manifestations in otolaryngology. Infect Dis Rep. 2012;4:e9.
  • Sanjar FA, Queiroz BE, Miziara ID. Otolaryngologic manifestations in HIV disease – clinical aspects and treatment. Braz J Otorhinolaryngol. 2011;77:391–400.
  • Werutsky G, De Carvalho GP, Da Silva VD, et al. AIDS-related sinonasal Burkitt lymphoma successfully treated with intensive chemotherapy régimen and high active antiretroviral therapy. Hematol Oncol Stem Cell Ther. 2011;4:41–44.
  • Stevens WW, Peters AT. Immunodeficiency in chronic sinusitis: recognition and treatment. Am J Rhinol Allergy. 2015;29:115–118.
  • Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2012;12:595–601.
  • Khalid AN, Mace JC, Smith TL. Outcomes of sinus surgery in ambulatory patients with immune dysfunction. Am J Rhinol Allergy. 2010;24:230–233.
  • Dao AM, Rereddy SK, Wise SK, et al. Management of non-invasive rhinosinusitis in the immunosuppressed patient population. Laryngoscope. 2015;125:1767–1771.
  • Patel ZM. Practice patterns regarding noninvasive rhinosinusitis in the immunosuppressed patient population. Allergy Rhinol (Providence). 2013;4:e151–4.
  • Rodriguez-Cortez VC, Del Pino-Molina L, Rodriguez-Ubreva J, et al. Dissecting epigenetic dysregulation of primary antibody deficiencies. J Clin Immunol. 2016;36:48–56.
  • Lee ST, Xiao Y, Muench MO, et al. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res. 2012;40:11339–11351.
  • Cahill KN, Raby BA, Zhou X, et al. Impaired E Prostanoid2 expression and resistance to prostaglandin E2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease. A J Respir Cell Mol Biol. 2016;54:34–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.